FDA commissioner Rob Califf (Tom Williams/CQ Roll Call via AP Images)

FDA com­mis­sion­er's vi­sion: Time to re­vamp the ev­i­dence gen­er­a­tion sys­tem

With an eye to­ward fin­ish­ing out Pres­i­dent Biden’s first term in of­fice, FDA com­mis­sion­er Rob Califf said Tues­day af­ter­noon that he’ll seek to ad­dress (on top of the in­fant for­mu­la and food-re­lat­ed fi­as­cos) mis­in­for­ma­tion and cre­at­ing new ways to bol­ster the wider ev­i­dence gen­er­a­tion sys­tem that the agency re­lies on to make ap­proval de­ci­sions.

While re­fer­ring to the FDA as both a “de­ci­sion-mak­ing ma­chine” and “in essence, a ref­er­ee that plays by a set of rules,” Califf made clear that his sec­ond stint as FDA com­mis­sion­er will be fo­cused more on the em­brace of new da­ta, per­haps harken­ing back to his re­cent work with Google’s par­ent com­pa­ny Al­pha­bet, where he led the firm’s health strat­e­gy and pol­i­cy side.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.